HomeAI · summaries
Storia in 6 fonti
FDA Reverses Course, Will Review Moderna's mRNA Flu Vaccine
Moderna said the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
huffpost.com
FDA Reverses Course, Will Review Moderna's mRNA Flu Vaccine
Moderna said the U.S. Food and Drug Administration has agreed to review its influenza vaccine, reversing an earlier decision to reject the application.
- ·
ft.com
Trump administration reverses move to block Moderna flu vaccine trial
U-turn comes after backlash from the company and US biotech industry
- ·
cnbc.com
FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal
The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season.
- ·
arstechnica.com
FDA reverses surprise rejection of Moderna's mRNA flu vaccine
Trump admin's vaccine chief overruled FDA scientists to initially reject the shot.
- ·
aljazeera.com
US says that it will review Moderna flu vaccine it previously declined
The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns.
- ·
upi.com
FDA plans review of Moderna flu vaccine for older adults - UPI.com
Moderna's mRNA-1010 flu vaccine for older adults could be made available by the end of 2026, the pharmaceutical company announced on Friday.